Association of plasma bilirubin with coronary heart disease and segregation of bilirubin as a major gene trait

The NHLBI family heart study

Steven Hunt, Florian Kronenberg, John H. Eckfeldt, Paul N. Hopkins, Richard H. Myers, Gerardo Heiss

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

Decreased serum bilirubin levels have been associated with coronary heart disease (CHD). It is believed that bilirubin acts as an antioxidant, preventing formation of oxidized LDL and subsequent atherosclerosis. Serum bilirubin also segregates as a major gene, with the rarer genotype associated with elevated bilirubin levels and occurring in about 12% of the population. Using a large population-based study of random and CHD high risk families, this analysis was designed to replicate the association of lower serum bilirubin levels with early CHD (onset by age 55 for males and 65 for females) using 328 case/control samples and the major gene segregation of bilirubin levels in 555 families. There were significant differences in plasma bilirubin levels between 188 males (12.5 μmol/l) and 140 females (9.3 μmol/l, P < 0.0001). Higher serum albumin and lower HDL-C significantly correlated with higher plasma bilirubin levels in females but not males. In sex-specific logistic regression models of early CHD (148 cases and 180 controls), lower plasma bilirubin was associated with increased prevalence of CHD in males with borderline significance (odds ratio = 0.93 for a 1 μmol/l increase in bilirubin, P = 0.056) but not in females. Bilirubin was found to segregate as a major gene using all 555 families consisting of 1292 individuals, with estimates replicating those in the previously published study. The most parsimonious model was a recessive model for high bilirubin levels that occurred in about 23% of the population. The means were separated by 1.7 standard deviations and there was a significant polygenic effect (h2 = 0.33, P = 0.0009). We conclude that decreased bilirubin is mildly related to CHD in males but not in females. Because of an inverse correlation between HDL-C and bilirubin, the protective high HDL-C levels may have counteracted the CHD risk associated with lower bilirubin levels in females. The inferred major gene for bilirubin may protect against CHD, since elevated levels, rather than lower levels, were associated with this inferred gene.

Original languageEnglish
Pages (from-to)747-754
Number of pages8
JournalAtherosclerosis
Volume154
Issue number3
DOIs
Publication statusPublished - 15 Feb 2001
Externally publishedYes

Fingerprint

National Heart, Lung, and Blood Institute (U.S.)
Bilirubin
Coronary Disease
Genes
Logistic Models
Serum
Population

Keywords

  • Antioxidants
  • Atherosclerosis
  • Bilirubin
  • Coronary heart disease
  • Epidemiology
  • Genetics
  • Lipids
  • Segregation analysis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Association of plasma bilirubin with coronary heart disease and segregation of bilirubin as a major gene trait : The NHLBI family heart study. / Hunt, Steven; Kronenberg, Florian; Eckfeldt, John H.; Hopkins, Paul N.; Myers, Richard H.; Heiss, Gerardo.

In: Atherosclerosis, Vol. 154, No. 3, 15.02.2001, p. 747-754.

Research output: Contribution to journalArticle

Hunt, Steven ; Kronenberg, Florian ; Eckfeldt, John H. ; Hopkins, Paul N. ; Myers, Richard H. ; Heiss, Gerardo. / Association of plasma bilirubin with coronary heart disease and segregation of bilirubin as a major gene trait : The NHLBI family heart study. In: Atherosclerosis. 2001 ; Vol. 154, No. 3. pp. 747-754.
@article{fad0dde79a76449ea53068ed649b5d03,
title = "Association of plasma bilirubin with coronary heart disease and segregation of bilirubin as a major gene trait: The NHLBI family heart study",
abstract = "Decreased serum bilirubin levels have been associated with coronary heart disease (CHD). It is believed that bilirubin acts as an antioxidant, preventing formation of oxidized LDL and subsequent atherosclerosis. Serum bilirubin also segregates as a major gene, with the rarer genotype associated with elevated bilirubin levels and occurring in about 12{\%} of the population. Using a large population-based study of random and CHD high risk families, this analysis was designed to replicate the association of lower serum bilirubin levels with early CHD (onset by age 55 for males and 65 for females) using 328 case/control samples and the major gene segregation of bilirubin levels in 555 families. There were significant differences in plasma bilirubin levels between 188 males (12.5 μmol/l) and 140 females (9.3 μmol/l, P < 0.0001). Higher serum albumin and lower HDL-C significantly correlated with higher plasma bilirubin levels in females but not males. In sex-specific logistic regression models of early CHD (148 cases and 180 controls), lower plasma bilirubin was associated with increased prevalence of CHD in males with borderline significance (odds ratio = 0.93 for a 1 μmol/l increase in bilirubin, P = 0.056) but not in females. Bilirubin was found to segregate as a major gene using all 555 families consisting of 1292 individuals, with estimates replicating those in the previously published study. The most parsimonious model was a recessive model for high bilirubin levels that occurred in about 23{\%} of the population. The means were separated by 1.7 standard deviations and there was a significant polygenic effect (h2 = 0.33, P = 0.0009). We conclude that decreased bilirubin is mildly related to CHD in males but not in females. Because of an inverse correlation between HDL-C and bilirubin, the protective high HDL-C levels may have counteracted the CHD risk associated with lower bilirubin levels in females. The inferred major gene for bilirubin may protect against CHD, since elevated levels, rather than lower levels, were associated with this inferred gene.",
keywords = "Antioxidants, Atherosclerosis, Bilirubin, Coronary heart disease, Epidemiology, Genetics, Lipids, Segregation analysis",
author = "Steven Hunt and Florian Kronenberg and Eckfeldt, {John H.} and Hopkins, {Paul N.} and Myers, {Richard H.} and Gerardo Heiss",
year = "2001",
month = "2",
day = "15",
doi = "10.1016/S0021-9150(00)00420-2",
language = "English",
volume = "154",
pages = "747--754",
journal = "Atherosclerosis",
issn = "0021-9150",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Association of plasma bilirubin with coronary heart disease and segregation of bilirubin as a major gene trait

T2 - The NHLBI family heart study

AU - Hunt, Steven

AU - Kronenberg, Florian

AU - Eckfeldt, John H.

AU - Hopkins, Paul N.

AU - Myers, Richard H.

AU - Heiss, Gerardo

PY - 2001/2/15

Y1 - 2001/2/15

N2 - Decreased serum bilirubin levels have been associated with coronary heart disease (CHD). It is believed that bilirubin acts as an antioxidant, preventing formation of oxidized LDL and subsequent atherosclerosis. Serum bilirubin also segregates as a major gene, with the rarer genotype associated with elevated bilirubin levels and occurring in about 12% of the population. Using a large population-based study of random and CHD high risk families, this analysis was designed to replicate the association of lower serum bilirubin levels with early CHD (onset by age 55 for males and 65 for females) using 328 case/control samples and the major gene segregation of bilirubin levels in 555 families. There were significant differences in plasma bilirubin levels between 188 males (12.5 μmol/l) and 140 females (9.3 μmol/l, P < 0.0001). Higher serum albumin and lower HDL-C significantly correlated with higher plasma bilirubin levels in females but not males. In sex-specific logistic regression models of early CHD (148 cases and 180 controls), lower plasma bilirubin was associated with increased prevalence of CHD in males with borderline significance (odds ratio = 0.93 for a 1 μmol/l increase in bilirubin, P = 0.056) but not in females. Bilirubin was found to segregate as a major gene using all 555 families consisting of 1292 individuals, with estimates replicating those in the previously published study. The most parsimonious model was a recessive model for high bilirubin levels that occurred in about 23% of the population. The means were separated by 1.7 standard deviations and there was a significant polygenic effect (h2 = 0.33, P = 0.0009). We conclude that decreased bilirubin is mildly related to CHD in males but not in females. Because of an inverse correlation between HDL-C and bilirubin, the protective high HDL-C levels may have counteracted the CHD risk associated with lower bilirubin levels in females. The inferred major gene for bilirubin may protect against CHD, since elevated levels, rather than lower levels, were associated with this inferred gene.

AB - Decreased serum bilirubin levels have been associated with coronary heart disease (CHD). It is believed that bilirubin acts as an antioxidant, preventing formation of oxidized LDL and subsequent atherosclerosis. Serum bilirubin also segregates as a major gene, with the rarer genotype associated with elevated bilirubin levels and occurring in about 12% of the population. Using a large population-based study of random and CHD high risk families, this analysis was designed to replicate the association of lower serum bilirubin levels with early CHD (onset by age 55 for males and 65 for females) using 328 case/control samples and the major gene segregation of bilirubin levels in 555 families. There were significant differences in plasma bilirubin levels between 188 males (12.5 μmol/l) and 140 females (9.3 μmol/l, P < 0.0001). Higher serum albumin and lower HDL-C significantly correlated with higher plasma bilirubin levels in females but not males. In sex-specific logistic regression models of early CHD (148 cases and 180 controls), lower plasma bilirubin was associated with increased prevalence of CHD in males with borderline significance (odds ratio = 0.93 for a 1 μmol/l increase in bilirubin, P = 0.056) but not in females. Bilirubin was found to segregate as a major gene using all 555 families consisting of 1292 individuals, with estimates replicating those in the previously published study. The most parsimonious model was a recessive model for high bilirubin levels that occurred in about 23% of the population. The means were separated by 1.7 standard deviations and there was a significant polygenic effect (h2 = 0.33, P = 0.0009). We conclude that decreased bilirubin is mildly related to CHD in males but not in females. Because of an inverse correlation between HDL-C and bilirubin, the protective high HDL-C levels may have counteracted the CHD risk associated with lower bilirubin levels in females. The inferred major gene for bilirubin may protect against CHD, since elevated levels, rather than lower levels, were associated with this inferred gene.

KW - Antioxidants

KW - Atherosclerosis

KW - Bilirubin

KW - Coronary heart disease

KW - Epidemiology

KW - Genetics

KW - Lipids

KW - Segregation analysis

UR - http://www.scopus.com/inward/record.url?scp=0035864610&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035864610&partnerID=8YFLogxK

U2 - 10.1016/S0021-9150(00)00420-2

DO - 10.1016/S0021-9150(00)00420-2

M3 - Article

VL - 154

SP - 747

EP - 754

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

IS - 3

ER -